Matrix Asset Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,929
| Closed | -$212K | – | 106 |
|
|
2025
Q4 | $212K | Buy |
+3,929
| New | +$189K | 0.02% | 103 |
|
|
2025
Q3 | – | Sell |
-4,729
| Closed | -$219K | – | 108 |
|
|
2025
Q2 | $219K | Buy |
4,729
+637
| +16% | +$31.3K | 0.02% | 103 |
|
|
2025
Q1 | $250K | Sell |
4,092
-1,357
| -25% | -$79.1K | 0.03% | 94 |
|
|
2024
Q4 | $308K | Sell |
5,449
-170
| -3% | -$9.5K | 0.03% | 87 |
|
|
2024
Q3 | $291K | Buy |
5,619
+15
| +0.3% | +$704 | 0.03% | 82 |
|
|
2024
Q2 | $233K | Buy |
5,604
+55
| +1% | +$2.46K | 0.03% | 93 |
|
|
2024
Q1 | $301K | Buy |
5,549
+109
| +2% | +$5.55K | 0.04% | 76 |
|
|
2023
Q4 | $279K | Hold |
5,440
| – | – | 0.04% | 82 |
|
|
2023
Q3 | $316K | Hold |
5,440
| – | – | 0.05% | 73 |
|
|
2023
Q2 | $348K | Sell |
5,440
-20
| -0.4% | -$1.34K | 0.05% | 76 |
|
|
2023
Q1 | $378K | Sell |
5,460
-1,190
| -18% | -$83.9K | 0.05% | 70 |
|
|
2022
Q4 | $478K | Hold |
6,650
| – | – | 0.07% | 68 |
|
|
2022
Q3 | $473K | Sell |
6,650
-35
| -0.5% | -$2.54K | 0.08% | 62 |
|
|
2022
Q2 | $515K | Sell |
6,685
-499
| -7% | -$38K | 0.08% | 61 |
|
|
2022
Q1 | $525K | Sell |
7,184
-997
| -12% | -$66.9K | 0.07% | 64 |
|
|
2021
Q4 | $510K | Sell |
8,181
-9
| -0.1% | -$528 | 0.07% | 65 |
|
|
2021
Q3 | $485K | Buy |
8,190
+6
| +0.1% | +$395 | 0.07% | 62 |
|
|
2021
Q2 | $547K | Buy |
8,184
+22
| +0.3% | +$1.44K | 0.08% | 58 |
|
|
2021
Q1 | $515K | Sell |
8,162
-2,497
| -23% | -$155K | 0.08% | 66 |
|
|
2020
Q4 | $661K | Buy |
10,659
+15
| +0.1% | +$922 | 0.11% | 60 |
|
|
2020
Q3 | $642K | Buy |
10,644
+10
| +0.1% | +$602 | 0.12% | 57 |
|
|
2020
Q2 | $625K | Sell |
10,634
-2
| -0% | -$120 | 0.12% | 53 |
|
|
2020
Q1 | $593K | Sell |
10,636
-1,064
| -9% | -$65K | 0.14% | 51 |
|
|
2019
Q4 | $751K | Sell |
11,700
-605
| -5% | -$34.6K | 0.12% | 52 |
|
|
2019
Q3 | $624K | Hold |
12,305
| – | – | 0.11% | 51 |
|
|
2019
Q2 | $558K | Buy |
12,305
+5
| +0% | +$233 | 0.1% | 54 |
|
|
2019
Q1 | $587K | Sell |
12,300
-2,934
| -19% | -$146K | 0.1% | 52 |
|
|
2018
Q4 | $792K | Sell |
15,234
-2,005
| -12% | -$108K | 0.15% | 50 |
|
|
2018
Q3 | $1.07M | Hold |
17,239
| – | – | 0.17% | 49 |
|
|
2018
Q2 | $954K | Sell |
17,239
-695
| -4% | -$37.5K | 0.16% | 50 |
|
|
2018
Q1 | $1.13M | Sell |
17,934
-30
| -0.2% | -$1.93K | 0.19% | 50 |
|
|
2017
Q4 | $1.1M | Sell |
17,964
-10
| -0.1% | -$625 | 0.17% | 49 |
|
|
2017
Q3 | $1.15M | Buy |
+17,974
| New | +$1.05M | 0.19% | 49 |
|
Other funds holding BMY
VCM
VPM
Matrix Asset Advisors's BMY Position: Q1 2026 in Review
Matrix Asset Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 3,929 shares — an estimated $212K sold.
Matrix Asset Advisors first reported a position in BMY in Q3 2017 and held it in 33 quarters. The position peaked at $1.15M in Q3 2017. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Matrix Asset Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Matrix Asset Advisors sold 3,929 Bristol-Myers Squibb shares in Q1 2026, an estimated $212K.
- Matrix Asset Advisors first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 33 quarters.
- Matrix Asset Advisors's Bristol-Myers Squibb position peaked at $1.15M in Q3 2017.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Matrix Asset Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.